Evidence map›Paper›PMID 32157318›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2020

H

M M Yurinskaya, G S Krasnov, D A Kulikova, O G Zatsepina, M G Vinokurov, L N Chuvakova, A P Rezvykh, S Y Funikov, A V Morozov, M B Evgen'ev

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Potent Bile Acid Microbial Metabolites ModulatePathogens (Basel, Switzerland) · 2023
    Article
  2. Article
  3. Article
  4. The Effects of HBiomedicines · 2022
    Article
  5. Hydrogen Sulfide (HCurrent neuropharmacology · 2022
    Review
  6. Article
  7. Sulfur-containing therapeutics in the treatment of Alzheimer's disease.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2021
    Article
  8. Article
  9. Hydrogen Sulfide and the Immune System.Advances in experimental medicine and biology · 2021
    Article
  10. Article
  11. Possible application of HCell stress & chaperones · 2020
    Article
  12. The Role of Host-Generated HFrontiers in cellular and infection microbiology · 2020
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

M M YurinskayaEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
G S KrasnovEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
D A KulikovaKoltzov Institute of Developmental Biology RAS, Moscow, 119991, Russia.
O G ZatsepinaEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
M G VinokurovInstitute of Cell Biophysics RAS, PSCBR RAS, Puschino, 142290, Russia.
L N ChuvakovaEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
A P RezvykhEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
S Y FunikovEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
A V MorozovEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia.
M B Evgen'evEngelhardt Institute of Molecular Biology RAS, Vavilov str. 32, Moscow, 119991, Russia. misha672011@yahoo.com.ORCID http://orcid.org/0000-0001-8554-2121
Engelhardt Institute of Molecular Biology · RUInstitute of Cell Biophysics · RUKoltzov Institute of Developmental Biology · RU

Funding

Russian grant Program for Basic Science 19-04-00109Russian Science Foundation 17-74-30030
6 · The paper itself

Abstract

backgroundHydrogen sulfide donors reduce inflammatory signaling in vitro and in vivo. The biological effect mediated by H

methodsWe investigated the effects of GYY4137 and sodium hydrosulfide on the release of proinflammatory molecules such as ROS, NO and TNF-α from LPS-treated human SH-SY5Y neuroblastoma and the THP-1 promonocytic cell lines. Transcriptomic and RT-qPCR studies using THP-1 cells were performed to monitor the effects of the GYY4137 on multiple signaling pathways, including various immune-related and proinflammatory genes after combined action of LPS and GYY4137.

resultsThe GYY4137 and sodium hydrosulfide differed in the ability to reduce the production of the LPS-evoked proinflammatory mediators. The pre-treatment with GYY4137 resulted in a drastic down-regulation of many TNF-α effectors that are induced by LPS treatment in THP-1 cells. Furthermore, GYY4137 pretreatment of LPS-exposed cells ameliorates the LPS-mediated induction of multiple pro-inflammatory genes and decreases expression of immunoproteasome genes. Besides, in these experiments we detected the up-regulation of several important pathways that are inhibited by LPS.

conclusionBased on the obtained results we believe that our transcriptomic analysis significantly contributes to the understanding of the molecular mechanisms of anti-inflammatory and cytoprotective activity of hydrogen sulfide donors, and highlights their potential against LPS challenges and other forms of inflammation.

Indexed as

Anti-Inflammatory AgentsCell LineCytokinesHumansHydrogen SulfideInflammationLipopolysaccharidesMorpholinesNitric OxideOrganothiophosphorus CompoundsReactive Oxygen SpeciesSignal TransductionSulfidesTranscriptomeAnti-Inflammatory AgentsCytokinesGYY 4137Hydrogen SulfideLipopolysaccharidesMorpholinesNitric OxideOrganothiophosphorus CompoundsReactive Oxygen Speciessodium bisulfideSulfidesH2S donorsHsps genesLPS challengePro-inflammatory pathwaysTranscriptome

Identifiers

PMID32157318
OpenAlexW3011380640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.